ALDH5A1
Succinate-semialdehyde dehydrogenase, mitochondrial
Also known as: SSADH, SSDH, SSDH_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51649
- Gene
- ALDH5A1
- Ensembl
- ENSG00000112294
- Chromosome
- 6
- Canonical length
- 535 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This protein belongs to the aldehyde dehydrogenase family of proteins. This gene encodes a mitochondrial NAD(+)-dependent succinic semialdehyde dehydrogenase. A deficiency of this enzyme, known as 4-hydroxybutyricaciduria, is a rare inborn error in the metabolism of the neurotransmitter 4-aminobutyric acid (GABA). In response to the defect, physiologic fluids from patients accumulate GHB, a compound with numerous neuromodulatory properties. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
535 residues, UniProt reviewed canonical sequence.
>P51649|ALDH5A1
1 MATCIWLRSC GARRLGSTFP GCRLRPRAGG LVPASGPAPG PAQLRCYAGR LAGLSAALLR
61 TDSFVGGRWL PAAATFPVQD PASGAALGMV ADCGVREARA AVRAAYEAFC RWREVSAKER
121 SSLLRKWYNL MIQNKDDLAR IITAESGKPL KEAHGEILYS AFFLEWFSEE ARRVYGDIIH
181 TPAKDRRALV LKQPIGVAAV ITPWNFPSAM ITRKVGAALA AGCTVVVKPA EDTPFSALAL
241 AELASQAGIP SGVYNVIPCS RKNAKEVGEA ICTDPLVSKI SFTGSTTTGK ILLHHAANSV
301 KRVSMELGGL APFIVFDSAN VDQAVAGAMA SKFRNTGQTC VCSNQFLVQR GIHDAFVKAF
361 AEAMKKNLRV GNGFEEGTTQ GPLINEKAVE KVEKQVNDAV SKGATVVTGG KRHQLGKNFF
421 EPTLLCNVTQ DMLCTHEETF GPLAPVIKFD TEEEAIAIAN AADVGLAGYF YSQDPAQIWR
481 VAEQLEVGMV GVNEGLISSV ECPFGGVKQS GLGREGSKYG IDEYLELKYV CYGGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALDH5A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- liver: 92 nTPM
- skeletal muscle: 54 nTPM
- basal ganglia: 39 nTPM
- cerebral cortex: 38 nTPM
- amygdala: 33 nTPM
- tongue: 32 nTPM
Single-cell type
- hepatocytes: 117 nCPM
- fallopian tube ciliated cells: 63 nCPM
- prostatic hillock cells: 57 nCPM
- myonuclei: 51 nCPM
- brain inhibitory neurons: 45 nCPM
- parietal cells: 41 nCPM
Immune cell
- naive CD4 T-cell: 3.8 nTPM
- naive CD8 T-cell: 3.4 nTPM
- plasmacytoid DC: 2.4 nTPM
- memory B-cell: 2.2 nTPM
- naive B-cell: 2 nTPM
- MAIT T-cell: 1.9 nTPM
Brain region
- midbrain: 71 nTPM
- thalamus: 69 nTPM
- hypothalamus: 68 nTPM
- cerebral cortex: 64 nTPM
- spinal cord: 60 nTPM
- basal ganglia: 57 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ALDH5A1.
Disease | AllUniProt
Conditions ALDH5A1 is implicated in, by any mechanism.
- Succinic semialdehyde dehydrogenase deficiency (SSADHD) MIM:271980
Disease | GeneticClinVar
150 pathogenic / likely-pathogenic of 904 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Succinate-semialdehyde dehydrogenase deficiency
- Inborn genetic diseases
- ALDH5A1-related disorder
- Likely inborn error of metabolism
- Arthrogryposis multiplex congenita
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.73
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- central nervous system development
- gamma-aminobutyric acid catabolic process
- glutamate metabolic process
- post-embryonic development
- succinate metabolic process
- synaptic transmission, GABAergic
Molecular functions
- identical protein binding
- succinate-semialdehyde dehydrogenase (NAD+) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aldehyde dehydrogenase domain
- Aldehyde dehydrogenase, cysteine active site
- Aldehyde/histidinol dehydrogenase
- Aldehyde dehydrogenase, N-terminal
- Aldehyde dehydrogenase, C-terminal
- Aldehyde dehydrogenase, glutamic acid active site
- Aldehyde dehydrogenase family
- Succinate semialdehyde dehydrogenase
- Aldehyde Dehydrogenase Superfamily
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALDH5A1 as an antibody target. Whether an autoantibody or antibody against ALDH5A1 could matter depends on whether native ALDH5A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALDH5A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ALDH5A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...